- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Sonoma Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. Sonoma Pharmaceuticals shares (SNOA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.56 – a decrease of 8.57% over the previous week. Sonoma Pharmaceuticals employs 10 staff and has a trailing 12-month revenue of around $12.7 million.
What's in this guide?
Our top picks for where to buy Sonoma Pharmaceuticals stock
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Complimentary access to a financial planner
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
How to buy Sonoma Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SNOA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Sonoma Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Sonoma Pharmaceuticals stock price (NASDAQ: SNOA)
Use our graph to track the performance of SNOA stocks over time.Sonoma Pharmaceuticals shares at a glance
Latest market close | $2.56 |
---|---|
52-week range | $2.52 - $9.37 |
50-day moving average | $3.09 |
200-day moving average | $3.84 |
Wall St. target price | $26.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.99 |
Is it a good time to buy Sonoma Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sonoma Pharmaceuticals price performance over time
Historical closes compared with the close of $2.5601 from 2024-11-15
1 week (2024-11-08) | -8.57% |
---|---|
1 month (2024-10-17) | -12.62% |
3 months (2024-08-16) | 924.04% |
6 months (2024-05-17) | 984.79% |
1 year (2023-11-17) | 1,506.09% |
---|---|
2 years (2022-11-17) | -93.99% |
3 years (2021-11-17) | 108.8 |
5 years (2019-11-15) | 121 |
Sonoma Pharmaceuticals financials
Revenue TTM | $12.7 million |
---|---|
Gross profit TTM | $4.5 million |
Return on assets TTM | -19.59% |
Return on equity TTM | -74.65% |
Profit margin | -35.91% |
Book value | $7.86 |
Market Capitalization | $3.5 million |
TTM: trailing 12 months
Sonoma Pharmaceuticals share dividends
We're not expecting Sonoma Pharmaceuticals to pay a dividend over the next 12 months.
Have Sonoma Pharmaceuticals's shares ever split?
Sonoma Pharmaceuticals's shares were split on a 1:20 basis on 29 August 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sonoma Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Sonoma Pharmaceuticals shares which in turn could have impacted Sonoma Pharmaceuticals's share price.
Sonoma Pharmaceuticals share price volatility
Over the last 12 months, Sonoma Pharmaceuticals's shares have ranged in value from as little as $2.52 up to $9.374. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sonoma Pharmaceuticals's is 1.378. This would suggest that Sonoma Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Sonoma Pharmaceuticals overview
Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis; and Pediacyn, an atopic dermatitis hydrogel. It also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for use in emergencies and on mucous membranes, cuts, abrasions, burns, and body surfaces; and Endocyn root canal irrigation solutions. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc.
Frequently asked questions
What percentage of Sonoma Pharmaceuticals is owned by insiders or institutions?Currently 1.508% of Sonoma Pharmaceuticals shares are held by insiders and 2.416% by institutions. How many people work for Sonoma Pharmaceuticals?
Latest data suggests 10 work at Sonoma Pharmaceuticals. When does the fiscal year end for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals's fiscal year ends in March. Where is Sonoma Pharmaceuticals based?
Sonoma Pharmaceuticals's address is: 5445 Conestoga Court, Boulder, CO, United States, 80301 What is Sonoma Pharmaceuticals's ISIN number?
Sonoma Pharmaceuticals's international securities identification number is: US83558L2043 What is Sonoma Pharmaceuticals's CUSIP number?
Sonoma Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 67575P108
More guides on Finder
-
Robinhood Now Let’s You Trade on the Outcome of the Presidential Election; Joining Kalshi and others.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question